Pfizer-BioNTech COVID-19 Vaccine 73% Effective In Children Younger Than Five Years During Omicron Surge, Analysis Suggests

The AP (8/23) reports, “Pfizer’s COVID-19 vaccine was 73% effective in protecting children younger than 5 as Omicron spread in the spring, the company announced Tuesday.” This updated analysis of “COVID-19 diagnoses between March and June in Pfizer’s ongoing study of the three-dose vaccine” found “21 COVID-19 cases among the 351 tots who got dummy shots – compared to just 13 among the 794 youngsters given three vaccine doses.” Vaccinations for the age group “opened in the U.S. in June,” but “only about 6% of youngsters ages 6 months through 4 years had gotten at least one dose of a COVID-19 vaccine by mid-August, according to the American Academy of Pediatrics.”